当前位置：首页 > 文献互助 > 互助详情

Influence of the exchange screening parameter on the performance of screened hybrid functionals复制

用户pnH5Tk3Lg44w 9天前 38 20 已完结

1. 系统已在2025-11-30 11:23:15对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1063/1.2404663复制

文献链接: https://pubs.aip.org/jcp/article/125/22/224106/953719/Influence-of-the-exchange-screening-parameter-on复制

其他信息:

出版社: AIP Publishing
作者: Aliaksandr V. Krukau; Oleg A. Vydrov; Artur F. Izmaylov; Gustavo E. Scuseria
全文下载地址: https://pubs.aip.org/aip/jcp/article-pdf/doi/10.1063/1.2404663/13263224/224106_1_online.pdf

上一篇：成人心脏手术围手术期用药专家共识（2025版）

下一篇：C5aR1 microglia exacerbate neuroinflammation and cerebral edema in acute brain injury

互助时间线

2025-11-23 15:54:17 [完结求助]

楼主确认了用户xjlYT5fDyavk应助的文件是正确的, 求助状态变成 已完结

2025-11-23 11:23:15 [上传文件]

用户xjlYT5fDyavk上传了文件(PDF 308.07 KB), 求助状态变成 待确认

2025-11-22 19:13:26 [发起求助]

最新发布的求助

A practical guide to large-scale docking 23分钟前
Bicyclo[1.1.1]pentane-Derived Building Blocks for Click Chemistry 27分钟前
Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review 52分钟前
{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 1小时前
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 2小时前
Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive … 2小时前
术后恶心呕吐诊疗指南（2025版） 3小时前
Organic A-cationsin metal halide perovskitephotovoltaics 3小时前
Optimizing SiN Composition for Enhanced Charge-Trapping in Next-Generation 3D NAND Flash Memories 4小时前
Increasing the dimensionality of transistors with hydrogels 4小时前
In vivo CAR T cell generation to treat cancer and autoimmune disease 4小时前
Targeting DNA Damage Repair Pathways Beyond PARP Inhibition 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com